))
Top Breast Cancer Research at ASCO 2024
Manage episode 421646679 series 3482052
Contenido proporcionado por Breastcancer.org. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Breastcancer.org o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified medical oncologist at the Valley-Mount Sinai Comprehensive Cancer Center in Paramus, NJ, summarizes the top breast cancer research.
Listen to the episode to hear Dr. Teplinsky explain:
the DESTINY- Breast06 study on Enhertu compared to chemotherapy for metastatic hormone-receptor-positive breast cancer
how circulating tumor DNA may help predict recurrence
descalating treatment to reduce the risk of side effects
322 episodios
Compartir
